Frontiers in Immunology (Sep 2024)

Biomarkers of lymph node metastasis in esophageal cancer

  • Ningzi Wu,
  • Junlan Cai,
  • Junfei Jiang,
  • Ye Lin,
  • Xiaoqing Wang,
  • Weiguang Zhang,
  • Mingqiang Kang,
  • Peipei Zhang

DOI
https://doi.org/10.3389/fimmu.2024.1457612
Journal volume & issue
Vol. 15

Abstract

Read online

Esophageal cancer (EC) is among the most aggressive malignancies, ranking as the seventh most prevalent malignant tumor worldwide. Lymph node metastasis (LNM) indicates localized spread of cancer and often correlates with a poorer prognosis, emphasizing the necessity for neoadjuvant systemic therapy before surgery. However, accurate identification of LNM in EC presents challenges due to the lack of satisfactory diagnostic techniques. Imaging techniques, including ultrasound and computerized tomography scans, have low sensitivity and accuracy in assessing LNM. Additionally, the existing serological detection lacks precise biomarkers. The intricate and not fully understood molecular processes involved in LNM of EC contribute to current detective limitations. Recent research has shown potential in using various molecules, circulating tumor cells (CTCs), and changes in the microbiota to identify LNM in individuals with EC. Through summarizing potential biomarkers associated with LNM in EC and organizing the underlying mechanisms involved, this review aims to provide insights that facilitate biomarker development, enhance our understanding of the underlying mechanisms, and ultimately address the diagnostic challenges of LNM in clinical practice.

Keywords